IMCR
Immunocore Holdings Plc
NASDAQ · Healthcare · Biotechnology · GB
$29.23
−2.66%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.08x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.59x
- Price / sales
- 3.73x
- Price / cash flow
- -26.72x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 2.63x
- EV / EBITDA
- 64.52x
- EV / EBIT
- -60.64x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026